Description
Vigilancia de efectos adversos severos comunes en quimioterapia: hematológicos
PRINCIPIO ACTIVO: CEFTAZIDIMA
enfermedad de Addison sin tratamiento
DOSIS: 240 MG
KEPPRA 1 G | Tabletas | Caja con 30 TAB | UCB
BACTOCIN 400 MG 8 TAB BUTILHIOSCINA-PARACETAMOL Vigilancia de efectos adversos severosPRINCIPIO ACTIVO: OFLOXACINO DOSIS: 400 MG FORMA FARMACUTICA: 8 TABLETAS PRESENTACIN: 1 CAJA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
NAIRTIRCERAFRIACORPNOURISH-PZA20 PANALAB
US$ 71.70
AQUACEL AG FOAM 12.5x12.5 cm CALCIO 600.00 MG
US$ 1909.05
recommand products
